Mablytics

Company profile

Mablytics company profile

Mablytics is a preclinical biotechnology startup working on immunotherapies that are given precisely using a unique target. Recent research has found that the novel target is strictly limited in normal tissues, but overexpressed in some malignancies. Immunotherapies aimed at this target have the potential to be extremely successful while causing minimal side effects. Mablytics is paving the way for a more effective and yet safer immunotherapy by discovering the target's unique expression and creating predictive biomarkers that assess the likelihood of benefit or toxicity from prospective medicines.